Activated porcine embryonic brain endothelial cells induce a proliferative human T-lymphocyte response

Cell Transplantation

Volumn 12, Issue 6, 2003, Pages 637-646

  Sumitran Holgersson, Suchitra ^a   Brevig, Thomas ^b   Widner, Håkan ^c   Holgersson, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Biotechnological Institute Denmark   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Antigen presentation; Endothelial cell; Neural transplantation; Parkinson's disease; Pig; T lymphocyte; Xenotransplantation

Indexed keywords

CD31 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; EMBRYO CELL; ENDOTHELIUM CELL; FETAL TISSUE TRANSPLANTATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNE RESPONSE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; VASCULAR ENDOTHELIUM; XENOTRANSPLANTATION;

ANIMALIA; MAMMALIA; SUIDAE; SUS SCROFA;

EID: 0141788229     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108747118     Document Type: Article

References (58)

1. Barker, R. A.; Ratcliffe, E.; McLaughlin, M.; Richards, A.; Dunnett, S. B. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease. J. Neurosci. 20:3415-3424; 2000.
2. Batten, P.; Yacoub, M. H.; Rose, M. L. Effect of human cytokines (IFN-γ, TNF-α, IL-1β, IL-4) on porcine endothelial cells: Induction of MHC and adhesion molecules and functional significance of these changes. Immunology 87:127-133; 1996.
3. Boer, G. J. Ethical issues in neurografting of human embryonic cells. Theor. Med. Bioeth. 20:461-475; 1999.
4. Brevig, T.; Holgersson, J.; Widner, H. Xenotransplantation for CNS repair: Immunological barriers and strategies to overcome them. Trends Neurosci. 23:337-344; 2000.
5. Brevig, T.; Kristensen, T.; Zimmer, J. Expression of major histocompatibility complex antigens and induction of human T-lymphocyte proliferation by astrocytes and macrophages from porcine fetal brain. Exp. Neurol. 159:474-483; 1999.
6. Brevig, T.; Meyer, M.; Kristensen, T.; Zimmer, J. Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-Gal antibodies and complement is not toxic for the dopaminergic neurons. Cell Transplant. 10:25-30; 2001.
7. Brevig, T.; Meyer, M.; Kristensen, T.; Zimmer, J.; Holgersson, J. Xenotransplantation for brain repair. Reduction of porcine donor tissue immunogenicity by treatment with anti-Gal antibodies and complement. Transplantation 72: 190-196; 2001.
8. Brevig, T.; Pedersen, E. B.; Kristensen, T.; Zimmer, J. Proliferative response of human T lymphocytes to porcine fetal brain cells. Cell Transplant. 6:571-577; 1997.
9. Davis, T. A.; Craighead, N.; Williams, A. J.; Scadron, A.; June, C. H.; Lee, K. P. Primary porcine endothelial cells express membrane-bound B7-2 (CD86) and a soluble factor that co-stimulate cyclosporin A-resistant and CD28-dependent human T cell proliferation. Int. Immunol. 8: 1099-1111; 1996.
10. Davis, T. A.; Robinson, D. H.; Lee, K. P.; Kessler, S. W. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: Requirement for cell-to-cell interactions and colony-stimulating factors. Blood 85:1751-1761; 1995.
11. Deacon, T.; Schumacher, J.; Dinsmore, J.; Thomas, C.; Palmer, P.; Kott, S.; Edge, A.; Penney, D.; Kassissieh, S.; Dempsey, P.; Isacson, O. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3:350-353; 1997.
12. Dunnett, S. B.; Björklund, A. Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature 399:A32-39; 1999.
13. Edge, A. S.; Gosse, M. M.; Dinsmore, J. Xenogeneic cell therapy: Current progress and future developments in porcine cell transplantation. Cell Transplant. 7:525-539; 1998.
14. Finsen, B. R.; Sorensen, T.; Castellano, B.; Pedersen, E. B.; Zimmer, J. Leukocyte infiltration and glial reactions in xenografts of mouse brain tissue undergoing rejection in the adult rat brain. A light and electron microscopical immunocytochemical study. J. Neuroimmunol. 32:159-183; 1991.
15. Galpern, W. R.; Burns, L. H.; Deacon, T. W.; Dinsmore, J.; Isacson, O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp. Neurol. 140:1-13; 1996.
16. Grasbon-Frodl, E. M.; Nakao, N.; Brundin, P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res. Bull. 39:341-347; 1996.
17. Hauser, R. A.; Freeman, T. B.; Snow, B. J.; Nauert, M.; Gauger, L.; Kordower, J. H.; Olanow, C. W. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol. 56:179-187; 1999.
18. Hauzenberger, E.; Hauzenberger, D.; Hultenby, K.; Holgersson, J. Porcine endothelium supports transendothelial migration of human leukocyte subpopulations. Anti-porcine VCAM-1 antibodies as species-specific blockers of transendothelial monocyte and NK cell migration. Transplantation 69:1837-1849; 2000.
19. He, Z.; She, R.; Sumitran-Holgersson, S.; Blomberg, P.; Islam, K. B.: Holgersson, J. The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells. Xenotransplantation 8:202-212; 2001.
20. Hollenbaugh, D.; Mischel-Petty, N.; Edwards, C. P.; Simon, J. C.; Denfeld, R. W.; Kiener, P. A.; Aruffo, A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33-40; 1995.
21. Horner, H. J.; Gage, F. H. Regenerating the damaged central nervous system. Nature 407:963-970; 2000.
22. Hu, S.; Chao, C. C.; Khanna, K. V.; Gekker, G.; Peterson, P. K.; Molitor, T. W. Cytokine and free radical production by porcine microglia. Clin. Immunol. Immunopathol. 78: 93-96; 1996.
23. Isacson, O.; Breakefield, X. O. Benefits and risks of hosting animal cells in the human brain. Nat. Med. 3:964-969; 1997.
24. Isacson, O.; Deacon, T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20:477-482; 1997.
25. Isacson, O.; Deacon, T. W.; Pakzaban, P.; Galpern, W. R.; Dinsmore, J.; Burns, L. H. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1:1189-1194; 1995.
26. Ivanoska, D.; Sun, D. C.; Lunney, J. K. Production of monoclonal antibodies reactive with polymorphic and monomorphic determinants of SLA class I gene products. Immunogenetics 33:220-223; 1991.
27. Kordower, J. H.; Freeman, T. B.; Olanow, C. W. Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Mov. Disord. 13:88-95; 1998.
28. Lakkis, F. G.; Arakelov, A.; Konieczny, B. T.; Inoue, Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-688; 2000.
29. Larsson, L. C.; Anderson, P.; Widner, H.; Korsgren, O. Enhanced survival of porcine neural xenografts in mice lacking the CD1.1, but no effect of NK1.1 depletion. Cell Transplant. 10:295-304; 2001.
30. Larsson, L. C.; Czech, K. A.; Brundin, P.; Widner, H. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: Immune responses and functional effects. Cell Transplant. 9:261-272; 2000.
31. Larsson, L. C.; Czech, K. A.; Widner, H.; Korsgren, O. Discordant neural tissue xenografts survive longer in immunoglobulin deficient mice. Transplantation 68:1153-1160; 1999.
32. Larsson, L. C.; Frielingsdorf, H.; Mirza, B.; Hansson, S. J.; Anderson, P.; Czech, K. A.; Strandberg, M.; Widner, H. Porcine neural xenografts in rats and mice: Donor tissue development and characteristics of rejection. Exp. Neurol. 172:100-114; 2001.
33. Lee, R. S.; Yamada, K.; Womer, K. L.; Pillsbury, E. P.; Allison, K. S.; Marolewski. A. E.; Geng, D.; Thall, A. D.; Arn, J. S.; Sachs, D. H.; Sayegh, M. H.; Madsen, J. C. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses. J. Immunol. 164:3434-3444; 2000.
34. Lindvall, O. Neural transplantation: A hope for patients with Parkinson's disease. Neuroreport 8:iii-x; 1997.
35. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C.; Marsden, C. D.; Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
36. Maher, S. E.; Karmann, K., Min, W.; Hughes, C. C. W.; Pober, J. S; Bothwell, A. L. M. Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells. Cloning, sequencing, and functional expression in human endothelial cells. J. Immunol. 157:3838-3844; 1996.
37. Murray, A. G.; Khodadoust, M. M.; Pober, J. S.; Bothwell, A. L. M. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1:57-63; 1994.
38. Nakao, N.; Frodl, E. M.; Duan, W. M.; Widner, H.; Brundin, P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. USA 91:12408-12412; 1994.
39. Okura, Y.; Tanaka, R.; Ono, K.; Yoshida, S.; Tanuma, N.; Matsumoto, Y. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: Tolerance induction by anti-T-cell antibodies. J. Neurosci. Res. 48:385-396; 1997.
40. Olanow, C. W.; Kordower, J. H.; Freeman, T. B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19:102-109; 1996.
41. Pakzaban, P.; Deacon, T. W.; Burns, L. H.; Dinsmore, J.; Isacson, O. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65:983-996; 1995.
42. Pakzaban, P.; Isacson, O. Neural xenotransplantation: Reconstruction of neuronal circuitry across species barriers. Neuroscience 62:989-1001; 1994.
43. Pennel, N. A.; Streit, W. J. Colonization of neural allografts by host microglial cells: Relationship to graft neovascularization. Cell Transplant. 6:221-230; 1997.
44. Peschanski, M.; Cesaro, P.; Hantraye, P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68:273-285; 1995.
45. Piccini, P.; Brooks, D. J.; Björklund, A.; Gunn, R. N.; Grasby, P. M.; Rimoldi, O.; Brundin, P.; Hagell, P.; Rehncrona, S.; Widner, H.; Lindvall, O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci. 2:1137-1140; 1999.
46. Pober, J. S. Immunobiology of human vascular endothelium. Immunologic Res. 19:225-232; 1999.
47. Rémy, S.; Canova, C.; Daguin-Nerrière, V.; Martin, C.; Melchior, B.; Neveu, I.; Charreau, B.; Soulillou, J.-P.; Brachet, P. Different mechanisms mediate the rejection of porcine neurons and endothelial cells transplanted into the rat brain. Xenotransplantation 8:136-148; 2001.
48. Robinson, D. H.; Kang, Y.-H.; Deschner, S. H.; Nielsen, T. B. Morphologic plasticity and periodicity: Porcine cerebral microvascular cells in culture. In Vitro Cell. Dev. Biol. 26:169-180; 1990.
49. Rollins, S. A.; Kennedy, S. P.; Chodera, A. J.; Elliott, E. A.; Zavoico, G. B.; Matis, L. A. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2. Transplantation 57: 1709-1716; 1994.
50. Rushworth, S. A.; Bravery, C. A.; Thomson, S. High sequence homology between human and pig CD40 with conserved binding to human CD154. Transplantation 69: 936-940; 2000.
51. Schumacher, J. M.; Ellias, S. A.; Palmer, E. P.; Kott, H. S.; Dinsmore, J.; Dempsey, P. K.; Fischman, A. J.; Thomas, C.; Feldman, R. G.; Kassissieh, S. ; Raineri, R.; Manhart, C.; Penney, D.; Fink, J. S.; Isacson, O. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54:1042-1050; 2000.
52. Sloan, D. J.; Wood, M. J.; Charlton, H. M. The immune response to intracerebral neural grafts. Trends Neurosci. 14:341-346; 1991.
53. Sumitran, S.; Anderson, P.; Widner, H.; Holgersson, J. Porcine embryonic brain cell cytotoxicity mediated by human natural killer cells. Cell Transplant. 8:601-610; 1999.
54. Sumitran, S.; Liu, J.; Czech, K. A.; Christensson, B.; Widner, H.; Holgersson, J. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Ga1α1,3Ga1-based xenoantigens. Exp. Neurol. 159:347-361; 1999.
55. Svendsen, C. N.; Smith, A. G. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci. 22:357-364; 1999.
56. Tadaki, D. K.; Craighead, N.; Saini, A.; Celniker, A.; Burkly, L. C.; Lee, K. P.; Chute, J. P.; Harlan, D. M.; Kirk, A. D. Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity. Transplantation 70:162-167; 2000.
57. Wennberg, L.; Czech, K. A.; Larsson, L. C.; Mirza, B.; Bennet, W.; Song, Z.; Widner, H. Effects of immunosuppressive treatment on host responses against intracerebral porcine neural tissue xenografts in rats. Transplantation 71:1797-1806; 2001.
58. Wood, M. J. A.; Sloan, D. J.; Wood, K. J.; Charlton, H. M. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies. Neuroscience 70: 775-789; 1996.